Poster Presentation Australian Society for Microbiology Annual Scientific Meeting 2024

Transcriptional Signatures Associated with the Survival of Escherichia coli Biofilm During Treatment with Plasma-Activated Water (#109)

Heema Vyas 1 2 , Md Mozammel Hoque 3 , Binbin Xia 2 , David Alam 2 , Patrick J Cullen 2 , Scott Rice 4 , Anne Mai-Prochnow 2
  1. The Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, NSW, Australia
  2. School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW, Australia
  3. Australian Institute for Microbiology & Infection, University of Technology Sydney, Sydney, NSW, Australia
  4. Agriculture and Food, Microbiomes for One Systems Health, Commonwealth Scientific and Industrial Research Organisation, Sydney, NSW, Australia

Biofilm formation on surfaces, tools and equipment can damage their quality and lead to high repair or replacement costs. Plasma-activated water (PAW), a new technology, has shown promise in killing biofilm and non-biofilm bacteria due to its mix of reactive oxygen and nitrogen species (RONS), and in particular superoxide. However, the specific genetic mechanisms behind PAW’s effectiveness, especially against biofilms, are not yet fully understood. Here, we examined the stress responses of Escherichia coli biofilms when exposed to sub-lethal PAW treatment with and without superoxide (by adding the scavenger Tiron to remove it). A 40% variation in gene expression was observed for PAW treated biofilms when compared to PAW-Tiron and controls. Specifically, PAW treatment resulted in 478 upregulated genes (> 1.5 log2FC) and 186 downregulated genes (< -1.5 log2FC) compared to the control. Pathway enrichment and biological process enrichment analysis revealed significant upregulation of sulfur metabolism, ATP-binding cassette transporter genes, amino acid metabolic/biosynthesis pathways, hypochlorite response systems and oxidative phosphorylation for biofilms treated with PAW compared to control. Knockout mutants of significantly upregulated genes associated with these pathways trxC (4.23-fold), cysP (1.58-fold) and nuoM (1.74-fold) were compared to the wild-type (WT) for their biofilm viability and intracellular RONS accumulation. Relative to PAW-treated WT, ∆trxC and ∆nuoM knockout mutants displayed significantly reduced biofilm viability (P ≤ 0.05) confirming their role in PAW-mediated response. Interestingly, ∆trxC biofilms had the highest intracellular ROS accumulation, as revealed by DCFDA staining after PAW treatment. This study gives a detailed insight into how E. coli biofilms respond to oxidative stress induced by PAW. It highlights the significance of superoxide in PAW's bactericidal effects. Overall, our findings shed light on the specific genes and pathways that help E. coli biofilms survive and respond to PAW treatment, offering a new understanding of plasma technology and its anti-biofilm mechanisms.